Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah W Gordon

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Anti-Cancer Drugs|March 7, 2024
A phase 1 study of regorafenib and sildenafil in adults with advanced solid tumorsAndrew S Poklepovic, Sarah W Gordon, Sejal Kothadia, et al.
International Journal of Pharmaceutics|March 30, 2025
Corrigendum to "An improved experimental model of osteosarcoma lung metastases to investigate innovative therapeutic interventions and sex as a biological variable" [Int. J. Pharm. 673 (2025) 125372]Fatemah S Sunbul, Rashed M Almuqbil, Hanming Zhang, et al.
International Journal of Pharmaceutics|February 19, 2025
An improved experimental model of osteosarcoma lung metastases to investigate innovative therapeutic interventions and sex as a biological variableFatemah S Sunbul, Rashed M Almuqbil, Hanming Zhang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 20, 2026
A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancerRobert M Wenham, Andrea L Buras, Sarah W Gordon, et al.
American Journal of Clinical Oncology|July 16, 2019
Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular CarcinomaSarah W Gordon, William P McGuire, Danielle A Shafer, et al.
Gynecologic Oncology|February 21, 2021
Post hoc analyses of GOG 9923: Does BRCA status affect toxicities?: An NRG oncology studyJessica Gillen, Austin Miller, Katherine M Bell-McGuinn, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Anti-Cancer Drugs|March 7, 2024
A phase 1 study of regorafenib and sildenafil in adults with advanced solid tumorsAndrew S Poklepovic, Sarah W Gordon, Sejal Kothadia, et al.
International Journal of Pharmaceutics|March 30, 2025
Corrigendum to "An improved experimental model of osteosarcoma lung metastases to investigate innovative therapeutic interventions and sex as a biological variable" [Int. J. Pharm. 673 (2025) 125372]Fatemah S Sunbul, Rashed M Almuqbil, Hanming Zhang, et al.
International Journal of Pharmaceutics|February 19, 2025
An improved experimental model of osteosarcoma lung metastases to investigate innovative therapeutic interventions and sex as a biological variableFatemah S Sunbul, Rashed M Almuqbil, Hanming Zhang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 20, 2026
A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancerRobert M Wenham, Andrea L Buras, Sarah W Gordon, et al.
American Journal of Clinical Oncology|July 16, 2019
Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular CarcinomaSarah W Gordon, William P McGuire, Danielle A Shafer, et al.
Gynecologic Oncology|February 21, 2021
Post hoc analyses of GOG 9923: Does BRCA status affect toxicities?: An NRG oncology studyJessica Gillen, Austin Miller, Katherine M Bell-McGuinn, et al.
Pageof 2